Joan Vern Lucca, RN, ANP | |
18 Three Ponds Dr, Brentwood, NH 03833-6659 | |
(603) 548-0811 | |
Not Available |
Full Name | Joan Vern Lucca |
---|---|
Gender | Female |
Speciality | Registered Nurse - Oncology |
Location | 18 Three Ponds Dr, Brentwood, New Hampshire |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1164045837 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
163WX0200X | Registered Nurse - Oncology | RN119032 (Massachusetts) | Primary |
Mailing Address | Practice Location Address |
---|---|
Joan Vern Lucca, RN, ANP 18 Three Ponds Dr, Brentwood, NH 03833-6659 Ph: (603) 548-0811 | Joan Vern Lucca, RN, ANP 18 Three Ponds Dr, Brentwood, NH 03833-6659 Ph: (603) 548-0811 |
News Archive
Professor Dame Sally Davies, the UK's Chief Medical Officer is warning that the world must do more to prevent the spread of infectious diseases.
Researchers from the RIKEN Center for Advanced Photonics and collaborators have discovered that terahertz radiation, contradicting conventional belief, can disrupt proteins in living cells without killing the cells.
State policymakers are growing increasingly anxious in the face of administration signals that key guidance on federal exchanges may not be coming until late 2011 or early 2012 — if they're coming at all. The administration appears to have decided that it does not need to issue a rule outlining the operation of a federal fallback exchange, according to sources familiar with the administration's thinking.
iBio, Inc. today announced successful production of human plasma proteins using its proprietary iBioLaunch technology. Human alpha 1-antitrypsin and human C1 esterase inhibitor were successfully produced at high yield in green plants via the Company's proprietary iBioLaunch technology. Both of these proteins are important therapeutic products, but until now they have been made from human blood.
› Verified 2 days ago